| Business Name: |
Dimopoulos Polyxeni MD |
| Contact Person: |
Polyxeni Dimopoulos |
| Address: |
6668 4th Section Road, Brockport, New York 14420 |
| Phone Number: |
(585) 368-6870 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Nwokonko Chiemeka J MD - Brockport, NY 14420
Saleh Amy M MD - Brockport, NY 14420
Rubins Jonathan MD - Brockport, NY 14420
Linder Mitchell MD - Brockport, NY 14420
Fairbanks Mary MD - Brockport, NY 14420
Karthikeyan Suri MD - Brockport, NY 14420
Mishkin Marc B MD - Brockport, NY 14420
Laidlaw Garth MD - Brockport, NY 14420
Maronian Hovaness MD - Brockport, NY 14420
Risolo John MD - Brockport, NY 14420
Salamone Frank N MD - Brockport, NY 14420
Mulbury Peter E MD - Brockport, NY 14420
Dimopoulos Jane MD - Brockport, NY 14420
Ghazi Ahmed MD - Brockport, NY 14420
Lakeside Health Syst Ortho Service - Brockport, NY 14420
Perez Brenda MD - Brockport, NY 14420
Cheryl Newman Pllc - Brockport, NY 14420
King Richard J MD - Brockport, NY 14420
Shah Syed A MD - Brockport, NY 14420
Jagdish Kamini MD - Brockport, NY 14420
|
The company Dimopoulos Polyxeni MD provides B2C services in the form of Doctors from its single location in New York.
1 to 4 employees work for Dimopoulos Polyxeni MD, and the business now earns $500.000 to $999.999 per annum.
Dimopoulos Polyxeni MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Dimopoulos Polyxeni MD, please call Polyxeni Dimopoulos with the phone number (585) 368-6870 or visit its single location at 6668 4th Section Road in Brockport, New York 14420.
The location of the single location can also be found using the coordinates 43.198414,-77.953033.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.